| Melissa L Johnson, MPT | |
|
10560 Old Olive Street Rd, Creve Coeur, MO 63141-5916 | |
| (314) 567-4707 | |
| Not Available |
| Full Name | Melissa L Johnson |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 10560 Old Olive Street Rd, Creve Coeur, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346387537 | NPI | - | NPPES |
| 1114090792 | Other | MO | GROUP NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 2005040573 (Missouri) | Primary |
| Provider Name | Fox Rehabilitation Services Pt Mo Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1750906095 PECOS PAC ID: 1254754948 Enrollment ID: O20200714002261 |
News Archive
British health officials have confirmed that the avian flu virus which killed 2,600 turkeys at a farm in Lowestoft, Suffolk was indeed the H5N1 virus.
A hospital trust has come up with warnings regarding nurses' uniforms and advised them against wearing clothes that expose their "midriff" or "excessive cleavage". East and North Hertfordshire NHS Trust has issued a new uniform policy for all staff, with guidance on shoes, clothing, hair length and colour. They have added that any member of staff who does not adhere to the policy could be subject to disciplinary action.
German regulators have approved the first clinical trial of a coronavirus vaccine. Developed by BioNTech SE, an immunotherapy company, and Pfizer, a pharmaceutical company, the potential coronavirus vaccine has completed pre-clinical studies in Germany.
Despite an expert panel stating last month that the three COX-2 drugs Vioxx, Bextra and Celebrex were safe enough to be marketed, the U.S. Food and Drug Administration (FDA) has this week told drug manufacturer Pfizer to remove the drug Bextra from the market and a statement by Pfizer confirms that the European Union regulators have done the same.
Timothy J. Yeatman, M.D., Moffitt's Associate Center Director for Clinical Investigations at the H. Lee Moffitt Cancer Center & Research Institute, and the Sarasota-based DNAPrintTM genomics, Inc., have formed a joint research program to develop and implement new clinical tests for predicting patient response to cancer chemotherapies.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa L Johnson, MPT 3115 Flatboat Station, Saint Charles, MO 63301-4781 Ph: () - | Melissa L Johnson, MPT 10560 Old Olive Street Rd, Creve Coeur, MO 63141-5916 Ph: (314) 567-4707 |
News Archive
British health officials have confirmed that the avian flu virus which killed 2,600 turkeys at a farm in Lowestoft, Suffolk was indeed the H5N1 virus.
A hospital trust has come up with warnings regarding nurses' uniforms and advised them against wearing clothes that expose their "midriff" or "excessive cleavage". East and North Hertfordshire NHS Trust has issued a new uniform policy for all staff, with guidance on shoes, clothing, hair length and colour. They have added that any member of staff who does not adhere to the policy could be subject to disciplinary action.
German regulators have approved the first clinical trial of a coronavirus vaccine. Developed by BioNTech SE, an immunotherapy company, and Pfizer, a pharmaceutical company, the potential coronavirus vaccine has completed pre-clinical studies in Germany.
Despite an expert panel stating last month that the three COX-2 drugs Vioxx, Bextra and Celebrex were safe enough to be marketed, the U.S. Food and Drug Administration (FDA) has this week told drug manufacturer Pfizer to remove the drug Bextra from the market and a statement by Pfizer confirms that the European Union regulators have done the same.
Timothy J. Yeatman, M.D., Moffitt's Associate Center Director for Clinical Investigations at the H. Lee Moffitt Cancer Center & Research Institute, and the Sarasota-based DNAPrintTM genomics, Inc., have formed a joint research program to develop and implement new clinical tests for predicting patient response to cancer chemotherapies.
› Verified 4 days ago
Sensory Solutions Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10560 Old Olive Street Rd, Suite 100, Creve Coeur, MO 63141 Phone: 314-567-4707 Fax: 314-567-4505 | |
Tanya Tepen, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 693 Decker Ln, Creve Coeur, MO 63141 Phone: 314-656-7578 Fax: 314-997-4532 | |
Mrs. Kristi M Johnson, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 11630 Studt Ave Ste 200, Creve Coeur, MO 63141 Phone: 314-733-9100 Fax: 314-733-9101 | |
Erin Ann Kimmins, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 10560 Old Olive Street Rd, Suite 100, Creve Coeur, MO 63141 Phone: 314-567-4707 Fax: 314-567-4505 | |
Caroline Markun, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 675 Old Ballas Rd, Creve Coeur, MO 63141 Phone: 314-310-6055 | |
Mrs. Kathleen M Monzyk, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 12539 Olive Blvd, Creve Coeur, MO 63141 Phone: 314-205-2006 Fax: 142-052-2413 | |
Sensory Solutions, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10560 Old Olive Street Rd, Suite 100, Creve Coeur, MO 63141 Phone: 314-567-4707 Fax: 314-567-4505 |